McGuire Investment Group LLC Sells 85 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

McGuire Investment Group LLC cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGGet Rating) by 0.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 24,802 shares of the medical equipment provider’s stock after selling 85 shares during the period. McGuire Investment Group LLC’s holdings in Intuitive Surgical were worth $4,978,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. LMR Partners LLP bought a new position in Intuitive Surgical during the fourth quarter worth about $636,000. Mitchell Mcleod Pugh & Williams Inc. lifted its holdings in Intuitive Surgical by 7.9% during the first quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 679 shares of the medical equipment provider’s stock worth $205,000 after acquiring an additional 50 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of Intuitive Surgical by 0.9% in the first quarter. Envestnet Asset Management Inc. now owns 440,904 shares of the medical equipment provider’s stock valued at $133,012,000 after purchasing an additional 3,982 shares in the last quarter. MCIA Inc lifted its holdings in shares of Intuitive Surgical by 5.6% in the first quarter. MCIA Inc now owns 3,596 shares of the medical equipment provider’s stock valued at $1,003,000 after purchasing an additional 190 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd lifted its holdings in shares of Intuitive Surgical by 2.6% in the second quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 37,616 shares of the medical equipment provider’s stock valued at $7,550,000 after purchasing an additional 952 shares in the last quarter. 82.44% of the stock is currently owned by institutional investors.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $0.56 during trading on Friday, reaching $190.52. 72,527 shares of the company’s stock were exchanged, compared to its average volume of 1,720,567. The business has a 50 day moving average price of $219.31 and a 200-day moving average price of $233.72. The stock has a market capitalization of $68.04 billion, a P/E ratio of 48.62, a PEG ratio of 5.43 and a beta of 1.31. Intuitive Surgical, Inc. has a fifty-two week low of $186.83 and a fifty-two week high of $369.69.

Intuitive Surgical (NASDAQ:ISRGGet Rating) last announced its quarterly earnings results on Thursday, July 21st. The medical equipment provider reported $0.85 earnings per share for the quarter, missing analysts’ consensus estimates of $1.04 by ($0.19). The business had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.56 billion. Intuitive Surgical had a return on equity of 12.04% and a net margin of 24.05%. During the same period last year, the firm earned $1.42 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 3.76 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of a number of research reports. Piper Sandler boosted their price target on Intuitive Surgical from $255.00 to $260.00 and gave the company an “overweight” rating in a report on Thursday, August 18th. BTIG Research cut their price target on Intuitive Surgical from $355.00 to $247.00 and set a “buy” rating on the stock in a report on Monday, July 18th. The Goldman Sachs Group cut their price target on Intuitive Surgical from $319.00 to $273.00 and set a “buy” rating on the stock in a report on Friday, July 29th. Wells Fargo & Company cut their price target on Intuitive Surgical to $265.00 in a report on Friday, July 22nd. Finally, Morgan Stanley cut their price target on Intuitive Surgical from $300.00 to $225.00 and set an “equal weight” rating on the stock in a report on Friday, July 15th. Six analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $268.00.

Insider Transactions at Intuitive Surgical

In other news, Director Amal M. Johnson sold 6,375 shares of the business’s stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now owns 11,224 shares in the company, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, Director Amal M. Johnson sold 6,375 shares of the business’s stock in a transaction that occurred on Wednesday, August 3rd. The stock was sold at an average price of $238.04, for a total transaction of $1,517,505.00. Following the completion of the sale, the director now owns 11,224 shares in the company, valued at $2,671,760.96. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 9,000 shares of the business’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $225.00, for a total value of $2,025,000.00. Following the sale, the executive vice president now owns 217 shares of the company’s stock, valued at approximately $48,825. The disclosure for this sale can be found here. Insiders sold a total of 101,162 shares of company stock worth $22,062,916 over the last quarter. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Company Profile

(Get Rating)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.